Investigators 0 13 0 13 O
will 14 18 14 18 O
enroll 19 25 19 25 O
children 26 34 26 34 O
ages 35 39 35 39 B-age
6 40 41 40 41 B-lower_bound
- 42 43 42 43 O
17 44 46 44 46 B-upper_bound
years 47 52 47 52 I-upper_bound
( 53 54 53 54 O
inclusive 54 63 54 63 O
) 63 64 63 64 O
with 65 69 65 69 O
a 70 71 70 71 O
previous 72 80 72 80 O
diagnosis 81 90 81 90 O
of 91 93 91 93 O
asthma 94 100 94 100 B-chronic_disease
who 101 104 101 104 O
present 105 112 105 112 O
in 113 115 113 115 O
an 116 118 116 118 O
acute 119 124 119 124 B-chronic_disease
exacerbation 125 137 125 137 I-chronic_disease
to 138 140 138 140 O
the 141 144 141 144 O
Pediatric 145 154 145 154 O
Emergency 155 164 155 164 O
Department 165 175 165 175 O

Patients 0 8 176 184 O
who 9 12 185 188 O
have 13 17 189 193 O
received 18 26 194 202 O
additional 27 37 203 213 O
adjunctive 38 48 214 224 B-treatment
therapies 49 58 225 234 I-treatment
beyond 59 65 235 241 O
repeated 66 74 242 250 O
SABA 75 79 251 255 B-treatment
and 80 83 256 259 O
atrovent 84 92 260 268 B-treatment
nebulizers 93 103 269 279 I-treatment
or 104 106 280 282 O
those 107 112 283 288 O
who 113 116 289 292 O
have 117 121 293 297 O
received 122 130 298 306 O
SCS 131 134 307 310 B-treatment
greater 135 142 311 318 O
than 143 147 319 323 O
1 148 149 324 325 B-lower_bound
hour 150 154 326 330 I-lower_bound
prior 155 160 331 336 I-lower_bound
to 161 163 337 339 O
initial 164 171 340 347 O
ED 172 174 348 350 O
evaluation 175 185 351 361 O
, 185 186 361 362 O
those 187 192 363 368 O
who 193 196 369 372 O
have 197 201 373 377 O
received 202 210 378 386 O
intravenous 211 222 387 398 B-treatment
magnesium 223 232 399 408 I-treatment
sulfate 233 240 409 416 I-treatment
infusion 241 249 417 425 I-treatment
, 249 250 425 426 O
or 251 253 427 429 O
subcutaneous 254 266 430 442 B-treatment
terbutaline 267 278 443 454 I-treatment
or 279 281 455 457 O
epinephrine 282 293 458 469 B-treatment
will 294 298 470 474 O
be 299 301 475 477 O
excluded 302 310 478 486 O

Patients 0 8 487 495 O
who 9 12 496 499 O
have 13 17 500 504 O
received 18 26 505 513 O
nebulized 27 36 514 523 O
bronchodilator 37 51 524 538 B-treatment
medications 52 63 539 550 I-treatment
at 64 66 551 553 O
either 67 73 554 560 O
a 74 75 561 562 O
referring 76 85 563 572 O
facility 86 94 573 581 O
or 95 97 582 584 O
at 98 100 585 587 O
home 101 105 588 592 O
will 106 110 593 597 O
be 111 113 598 600 O
included 114 122 601 609 O

Patients 0 8 610 618 O
who 9 12 619 622 O
present 13 20 623 630 O
from 21 25 631 635 O
a 26 27 636 637 O
referring 28 37 638 647 O
facility 38 46 648 656 O
or 47 49 657 659 O
Primary 50 57 660 667 O
Care 58 62 668 672 O
Physician 63 72 673 682 O
( 73 74 683 684 O
PCP 74 77 684 687 O
) 77 78 687 688 O
and 79 82 689 692 O
have 83 87 693 697 O
received 88 96 698 706 O
systemic 97 105 707 715 B-treatment
corticosteroids 106 121 716 731 I-treatment
( 122 123 732 733 I-treatment
SCS 123 126 733 736 I-treatment
) 126 127 736 737 I-treatment
within 128 134 738 744 O
one 135 138 745 748 B-upper_bound
hour 139 143 749 753 I-upper_bound
of 144 146 754 756 O
initial 147 154 757 764 O
AAIRS 155 160 765 770 O
scoring 161 168 771 778 O
will 169 173 779 783 O
also 174 178 784 788 O
be 179 181 789 791 O
included 182 190 792 800 O

Patients 0 8 801 809 O
will 9 13 810 814 O
be 14 16 815 817 O
evaluated 17 26 818 827 O
using 27 32 828 833 O
the 33 36 834 837 O
Acute 37 42 838 843 B-clinical_variable
Asthma 43 49 844 850 I-clinical_variable
Intensity 50 59 851 860 I-clinical_variable
Research 60 68 861 869 I-clinical_variable
Score 69 74 870 875 I-clinical_variable
( 75 76 876 877 I-clinical_variable
AAIRS 76 81 877 882 I-clinical_variable
) 81 82 882 883 I-clinical_variable
which 83 88 884 889 O
has 89 92 890 893 O
been 93 97 894 898 O
validated 98 107 899 908 O
at 108 110 909 911 O
Vanderbilt 111 121 912 922 O
University 122 132 923 933 O
Medical 133 140 934 941 O
Center 141 147 942 948 O
and 148 151 949 952 O
is 152 154 953 955 O
currently 155 164 956 965 O
the 165 168 966 969 O
standard 169 177 970 978 O
of 178 180 979 981 O
care 181 185 982 986 O
when 186 190 987 991 O
triaging 191 199 992 1000 O
patients 200 208 1001 1009 O
with 209 213 1010 1014 O
asthma 214 220 1015 1021 B-chronic_disease

Patients 0 8 1022 1030 O
with 9 13 1031 1035 O
a 14 15 1036 1037 O
history 16 23 1038 1045 O
of 24 26 1046 1048 O
spontaneous 27 38 1049 1060 B-chronic_disease
pneumothorax 39 51 1061 1073 I-chronic_disease
, 51 52 1073 1074 O
recent 53 59 1075 1081 O
facial 60 66 1082 1088 B-treatment
, 66 67 1088 1089 O
oral 68 72 1090 1094 B-treatment
or 73 75 1095 1097 O
skull 76 81 1098 1103 B-treatment
surgery 82 89 1104 1111 I-treatment
/ 89 90 1111 1112 O
trauma 90 96 1112 1118 O
, 96 97 1118 1119 O
history 98 105 1120 1127 O
of 106 108 1128 1130 O
esophageal 109 119 1131 1141 B-treatment
surgery 120 127 1142 1149 I-treatment
, 127 128 1149 1150 O
known 129 134 1151 1156 O
or 135 137 1157 1159 O
suspected 138 147 1160 1169 O
tympanic 148 156 1170 1178 O
membrane 157 165 1179 1187 O
rupture 166 173 1188 1195 O
or 174 176 1196 1198 O
other 177 182 1199 1204 O
middle 183 189 1205 1211 O
ear 190 193 1212 1215 O
pathology 194 203 1216 1225 O
, 203 204 1225 1226 O
acute 205 210 1227 1232 B-chronic_disease
sinusitis 211 220 1233 1242 I-chronic_disease
, 220 221 1242 1243 O
epistaxis 222 231 1244 1253 B-chronic_disease
, 231 232 1253 1254 O
active 233 239 1255 1261 O
hemoptysis 240 250 1262 1272 B-chronic_disease
or 251 253 1273 1275 O
nausea 254 260 1276 1282 O
will 261 265 1283 1287 O
be 266 268 1288 1290 O
excluded 269 277 1291 1299 O
as 278 280 1300 1302 O
these 281 286 1303 1308 O
are 287 290 1309 1312 O
contraindications 291 308 1313 1330 O
for 309 312 1331 1334 O
AccuPAP 313 320 1335 1342 O
use 321 324 1343 1346 O

Those 0 5 1347 1352 O
patients 6 14 1353 1361 O
whose 15 20 1362 1367 O
parents 21 28 1368 1375 O
are 29 32 1376 1379 O
require 33 40 1380 1387 O
a 41 42 1388 1389 O
translator 43 53 1390 1400 O
for 54 57 1401 1404 O
consent 58 65 1405 1412 O
will 66 70 1413 1417 O
also 71 75 1418 1422 O
be 76 78 1423 1425 O
excluded 79 87 1426 1434 O
( 88 89 1435 1436 O
ie 89 91 1436 1438 O
, 91 92 1438 1439 O
exclusively 93 104 1440 1451 O
Spanish 105 112 1452 1459 B-language_fluency
speaking 113 121 1460 1468 I-language_fluency
or 122 124 1469 1471 O
other 125 130 1472 1477 O
non 131 134 1478 1481 B-language_fluency
- 134 135 1481 1482 I-language_fluency
English 135 142 1482 1489 I-language_fluency
speaking 143 151 1490 1498 I-language_fluency
families 152 160 1499 1507 O
/ 160 161 1507 1508 O
patients 161 169 1508 1516 O
) 169 170 1516 1517 O

any 0 3 1518 1521 O
condition 4 13 1522 1531 O
precluding 14 24 1532 1542 O
a 25 26 1543 1544 O
patient 27 34 1545 1552 O
from 35 39 1553 1557 O
receiving 40 49 1558 1567 O
beta 50 54 1568 1572 B-treatment
- 54 55 1572 1573 I-treatment
agonist 55 62 1573 1580 I-treatment
therapy 63 70 1581 1588 I-treatment
( 71 72 1589 1590 O
ie- 72 75 1590 1593 O
predisposition 76 90 1594 1608 O
to 91 93 1609 1611 O
Supraventricular 94 110 1612 1628 B-chronic_disease
Tachycardia 111 122 1629 1640 I-chronic_disease
) 122 123 1640 1641 O

other 0 5 1642 1647 O
medical 6 13 1648 1655 O
conditions 14 24 1656 1666 O
contributing 25 37 1667 1679 O
to 38 40 1680 1682 O
respiratory 41 52 1683 1694 B-chronic_disease
distress 53 61 1695 1703 I-chronic_disease
( 62 63 1704 1705 O
e.g. 63 67 1705 1709 O
, 67 68 1709 1710 O
pneumonia 69 78 1711 1720 B-chronic_disease
, 78 79 1720 1721 O
cystic 80 86 1722 1728 B-chronic_disease
fibrosis 87 95 1729 1737 I-chronic_disease
, 95 96 1737 1738 O
anaphylaxis 97 108 1739 1750 B-allergy_name
) 108 109 1750 1751 O

